A study says ribociclib, a drug approved for treating advanced-stage breast cancer, may help reduce the risk of recurrence in women who have been treated for certain types of early-stage breast cancer. Research is ongoing.
from WebMD Health https://www.webmd.com/cancer/asco-2023-special-report/20230614/breast-cancer-drug-iyengar?src=RSS_PUBLIC
0 Comments:
Post a Comment